Cointime update: China’s newly released national medical insurance drug list includes 51 Class 1 innovative drugs, a record high, covering oncology treatments, rare disease therapies and novel-mechanism drugs for chronic conditions. The update reflects faster R&D output being matched by stable reimbursement coverage as innovative drugs move from the lab to clinical use.
China’s 2025 Medical Insurance Drug List Adds 51 Innovative Drugs, a Record High
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
6m ago
Iran military says it struck US drone and missile facilities at Kuwait’s Ali Al Salem base
1h ago
BOJ’s Ueda Says Rate Hikes Should Continue to Anchor Inflation
1h ago
South Korea’s KOSPI Turns Negative After Earlier Gaining Over 3%
2h ago
Spot silver falls 2.00% intraday to $46.44/oz, lowest since Sept 29, 2025
2h ago
Spot gold falls below $3,800/oz for first time since Sept 30
5h ago
CME FedWatch: 96.8% Odds of 25bps Fed Rate Hike in December